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and Vincenzo Denaro
Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico University of Rome, Rome, Italy
Chronic tendinopathy is a painful common condition affecting athletes as well as the
general population undergoing to tendon overuse. Although its huge prevalence, little is
known about tendinopathy pathogenesis, and even cloudier is its treatment. Traditionally,
tendinopathy has been defined as a lack of tendon ability to overcome stressing stimuli
with appropriate adaptive changes. Histologic studies have demonstrated the absence
of inflammatory infiltrates, as a consequence conventional antinflammatory drugs have
shown little or no effectiveness in treating tendinopathies. New strategies should be
therefore identified to address chronic tendon disorders. Angiofibroblastic changes
have been highlighted as the main feature of tendinopathy, and vascular endothelial
growth factor (VEGF) has been demonstrated as one of the key molecules involved
in vascular hyperplasia. More recently, attention has been focused on new peptides
such as Substance P, nitric oxide, and calcitonin gene-related peptide (CGRP). Those
new findings support the idea of a nerve-mediated disregulation of tendon metabolism.
Each of those molecules could be a target for new treatment options. This study aimed
to systematically review the current available clinical and basic science in order to
summarize the latest evidences on the pathophysiology and its effect on treatment of
chronic tendinopathy, and to spread suggestions for future research on its treatment.
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INTRODUCTION
With the increasing number of amateur sport practitioners, a growing prevalence of tendinopathy
has been recorded in the last few years in Europe and United States (Andia and Maffulli, 2015),
affecting mainly Achilles tendon, rotator cuff, extensor tendons at the lateral epicondyle of the
elbow and patellar tendon (Huang et al., 2004; Papalia et al., 2013). It has been described
as an altered healing response of the tendon to stressful conditions (Papalia et al., 2013),
including repetitive microtrauma, overloads, and acute and chronic injuries. The huge prevalence,
the invalidating symptoms, the long time needed to return to activities, and the challenging
management of chronic tendinopathies, rise concerns about the best treatment for these diseases.
Apart from surgery, a prompt clinical benefit is usually achieved by bed rest, topic, or systemic
drugs (including, NSAID’s) (Crisp et al., 2008; Zhang et al., 2013), taping, cryotherapy, ormodalities
such as laser therapy and shockwaves (Steunebrink et al., 2013). However, an integrated treatment
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that considers the biologic pattern related to tendinopathy is
far to be defined (Andia and Maffulli, 2015). At present, a
growing effort in the scientific literature is aimed to understand
the whole array of molecular and structural changes that are
involved in the pathogenesis of tendinopathy. Despite the recent
development and diffusion of biological therapies such as Platelet
Rich Plasma (PRP) and mesenchymal stem cells, most surgeons
ignore the basic science that underlies the molecular targets of
these treatments.
At the end of the biological processes that lead to tendon
tissue healing, we acknowledge the synthesis of collagen, which
is achieved by an increase in the number and in the function of
fibroblasts. This process has already been investigated in several
studies (Connell et al., 2009; Clarke et al., 2011; Ahmad et al.,
2012) reporting on the results of direct injection of dermal
fibroblasts (Ahmad et al., 2012) or mesenchymal bone marrow
cells (Ellera Gomes et al., 2012). Next to that, several other
biologic items have been investigated, including the pathways
of major molecules that have been found relevant in the
pathogenesis of tendinopathy, either considering the role of
vascular supply and innervation of the tendon. Specifically,
concerning the vascular function, the molecules that have been
investigated include the Vascular Endothelial Growth Factor
(VEGF), the Hypoxia Inducible Factor (HIF), and the Nitric
Oxide (NO); regarding the neurotransmitters, scientists mainly
studied substance P (SP), Neurokinin-1 (N-1) and Calcitonin
Gene-Related Peptide (CGRP). Several experimental studies
aimed to stimulate the healing pathways acting directly on these
molecular targets, showing promising results.
The aim of the present review of the literature is to explore
the current literature regarding the role of vascular and neuronal
molecular pathways in the pathogenesis and healing process
of tendinopathy. Furthermore, the therapeutic implications of
those pathways have been evaluated and shown in the below
paragraphs.
MATERIALS AND METHODS
Articles research has been carried out using PubMed online
database (http://www.ncbi.nlm.nih.gov/pubmed), between
June and August 2015. The combinations of key-words used
were the following: “(“tendinopathy”[MeSH Terms] OR
“tendinopathy”[All Fields]) AND (“vascular endothelial growth
factor a”[MeSH Terms] OR “vascular endothelial growth factor
a”[All Fields] OR “vegf”[All Fields]),” “(“tendinopathy”[MeSH
Terms] OR “tendinopathy”[All Fields]) AND (“substance
p”[MeSH Terms] OR “substance p”[All Fields] OR “p
substance”[All Fields]),” “(“tendinopathy”[MeSH Terms]
OR “tendinopathy”[All Fields]) AND (“neurotransmitter
agents”[Pharmacological Action] OR “neurotransmitter
agents”[MeSH Terms] OR (“neurotransmitter”[All Fields] AND
“agents”[All Fields]) OR “neurotransmitter agents”[All Fields]
OR “neurotransmitter”[All Fields]).” The search was aimed
to retrieve any level of evidence studies concerning molecular
pathways involved in pathogenesis of tendinopathy, clinical
associated features and therapeutic implications. Both clinical
and experimental in vivo and in vitro studies were included.
No study types were excluded except for literature reviews and
case reports. No time interval for publication was set. Of each
of the retrieved articles, the whole bibliography was carefully
checked to enrich the research with possible studies relevant for
the present work. Results of the studies were read, analyzed, and
tabulated. The included studies have been divided into three
categories: vascular function, nervous function, and therapeutic
studies. The study selection process was carried out as shown in
Figure 1.
RESULTS
Vascular Function (Table 1)
Behavior of Endogenous Angiogenetic Factors in
Tendinopathy
Studies have demonstrated that neovascularization is one of
the main features of tendinopathy (Zanetti et al., 2003; Rees
et al., 2006) and that it is mainly a VEGF-driven process
(Abraham et al., 2002; Yamazaki and Morita, 2006). In normal,
asymptomatic adult tendons, the expression of VEGF is mostly
suppressed, while in chronic overused tendons, VEGF expression
is markedly increased in the early and late phases of the overuse
process (Perry et al., 2005). Many in vitro studies have showed
a close relation between cyclic strain and increased VEGF
expression. In a recent study (Mousavizadeh et al., 2014), it has
been found that cyclic strain applied to in vitro tendon cells yields
to angiogenetic factors gene expression and synthesis, including
angiopoietin like-4 (ANGPTL4), fibroblast growth factor-
2 (FGF-2), cyclooxygenase-2 (COX-2), sphingosine kinase-1
(SPHK1), (transforming growth factor) TGF-α, VEGF-A, and
VEGF-C. Comparable results were obtained by Petersen et al.
(2004), that showed an increased synthesis of VEGF and Hypoxia
Induced Factor-1α (HIF-1α) in fibroblasts cultures of rat tendons
when an intermittent strain stress was applied. Nakama et al.
(2006) found increased levels of VEGF and VEGFR-1 in tendons
stimulated with continuous loading, compared to unstimulated
tendons (p= 0.0001 and p= 0.046 respectively). An in vivo study
on rabbits, by means of specific exercise protocols, Andersson
et al. (2011b) showed an increase in tenocyte number and
vascularization at 3 and 6 weeks. At the 6-week control, also the
VEGF mRNA resulted overexpressed. Another in vivo study, by
Sahin et al. (2012), investigated the expression of VEGF, HIF-1α,
and MMP-3, and analyzed the tendons’ biomechanical features
in a tendinopathy model realized by freezing the rat’s patellar
tendon. At 7 days from the intervention, all the above-mentioned
factors were increased and the angiogenesis was abundant.
Furthermore, the biomechanical analysis showed a significant
reduction in maximum stress and Young’s module of the
frozen tendons when compared with normal tendons. In human
subjects, Scott et al. (2008), found that VEGF was overexpressed
in patellar tendinopathy and not in normal tendons; moreover
higher VEGF levels were detected in patients with symptoms
of less duration (12 vs. 32.8 months). Chen et al. (2008) found
postoperative increased levels of connective tissue growth factor
(CTGF), TGF-β, VEGF, and Insulin-like growth factor-1 (IGF-1)
after tendon repair in chicken models. Conversely, b-FGF
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FIGURE 1 | Selection process of the studies.
expression was downregulated, and Platelet-Derived Growth
Factor (PDGF) was slightly elevated. Consistently, Petersen et al.
(2004) found an increase in VEGF levels after Achilles’ tendon
tenotomy in sheeps. In this model, the splice variants VEGF120
and VEGF164 were especially increased, at 3 and 24 weeks
respectively. These findings demonstrate that VEGF is involved
in the in mechanism of angiogenesis and Achilles’ tendon repair.
Behavior of Endogenous Nitric Oxide in Tendinopathy
Studies concerning nitric oxide (NO) and nitric oxide synthase
(NOS) expression have been carried out, in order to evaluate
endothelial activation during tendinopathy and its effects on
tendon tissue. An overuse protocol applied to supraspinatus
tendons was evaluated by Szomor et al. (2001), that found
an increased expression of both inducible NOS (iNOS) and
constitutive NOS (eNOS), compared to controls. The same
authors found increased expression of iNOS and eNOS in
human rotator cuff specimens harvested during rotator cuff
repair surgeries (Szomor et al., 2001). However, NO seems to
be important in new tissue synthesis during tendon healing.
The NO-paracetamol association has been added to tendon
tissue during in vitro Achilles tendon healing harvested from
a murine model. Increased amount of collagen and improved
collagen reorganization were found (Murrell et al., 2008).
Murrell et al. (1997) showed a five-fold increase in NO
synthase activity 7 days after surgical division of rat Achilles
tendons, with levels approximating the baseline at day 14.
Moreover, when the activity of NO synthase was inhibited, a
significant reduction in cross-sectional area and in the load
to failure of the tendons was observed. Lin et al. (2001)
found similar outcomes after Achilles tendon surgery in rats,
showing increased expression of all the isoforms of NOS. A
study by Xia et al. (2006b) evaluated the role of iNOS in the
healing process of tendinopathy from a murine model. Three
groups were compared: group 1: wild-type (iNOS+/+); group
2: knock-out (iNOS−/−); and group 3: knockout (iNOS−/−)
+ systemic NO synthase inhibition through aminoguanidine
(AG) administration. When systematically inhibiting the NO
synthase in iNOS−/− mice (group 3), the cross-sectional area of
the healing Achilles tendon was significantly reduced. However,
no significant differences were found between the wild-type
(group 1) and the knock-out mice (group 2) concerning both
the cross-sectional area and biomechanical features of the
healing Achilles tendon. Moreover, the same authors (Xia et al.,
2006a) demonstrated an increased collagen synthesis in cultures
of human rotator cuff tenocytes when cells were exposed to
exogenous NO (in the form of S-nitro-N-acetyl-penicillamine),
and when these were transfected with the iNOS gene via an
adenovirus vector.
Nervous Function and Neuronal
Stimulation (Table 2)
Behavior of Endogenous Neurotransmitters in
Tendinopathy
It has been recently considered a role for neurotransmitters
in the evolution of tendinopathy. The main molecule that has
been investigated is Substance P (SP), which is known to play
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TABLE 1 | Vascular function studies.
Study Year Investigated
molecules
Type of
study
Type of sperimentation Role in pathogenesis Role in healing
Anitua et al. 2005 IGF-1, TGF-β-1,
PDGF-AB, VEGF, HGF,
EGF
In vivo Comparison of the effect of
platelet-poor and platelet-rich
cloth releasates (PPCR, PRCR)
and platelet-poor plasma (PPP)
on tendon cell cultures
PRCR induces
tenocytes proliferation
more than PPCR
Mousavizadeh
et al.
2014 ANGPTL4, FGF-2,
COX-2, SPHK1,
TGF-α, VEGF-A, and
VEGF-C
In vitro Strain protocol applied to tendon
cell cultures. Measurement of
gene expression and proteins
synthesis
Tendon cell strain
induces expression of
angiogenetic growth
factors
Petersen
et al.
2003 VEGF, HIF-1α In vitro Strain protocol applied to cell
culture (3T3 fibroblasts and rat
Achilles tendon cells) and
measurement of factors
expression
Cell strain increased
VEGF and HIF-1α
concentrations in
culture supernatant
Asundi et al. 2007 MMP-1, MMP-3, VEGF,
CTGF, COX-2, IL-1β,
COL-III, FBRN
In vivo In vivo cumulative load of tendon
vs. control and mRNA
expression measurement
No difference of mRNA
expression in loaded
and unloaded tendons
Sahin et al. 2012 VEGF, HIF-1α, MMP-3 In vivo In vivo frozen model of
tendinopathy was evaluated with
immunohistochemistry
HIF-1α, VEGF, and
MMP-3 increased after
intervention, and then
decreased after 14 and
28 days
Liang et al. 2012 HIF-1α, VEGF, Bnip3,
Bcl-2, Bcl-xL
In vitro Hypoxia protocol on tenocytes
cultures. Measurement of
HIF-1α, VEGF mRNA and pro-
and anti-apoptotic peptides
Hypoxia induced
overexpression of
HIF-1α, VEGF, Bnip3,
but not of Bcl-2 and
Bcl-xL
Hao Chen
et al.
2008 CTGF, TGF-β, VEGF,
IGF-1, bFGF, PDGF-B
In vivo Surgical repair and
post-operative harvesting of
tendon on in vivo chicken model
CTGF TGF-β, VEGF.
and IGF-1 were highly
expressed during early
healing period, bFGF
was downregulated,
and PDGF-B was
minimally expressed
Andersson
et al.
2010 VEGF mRNA In vivo Electrical in vivo stimulation and
passive flexion of triceps surae
on rabbit model. Tenocytes
number, VEGF mRNA, and
vascular density evaluation
Increased tenocyte
number at 3 and 6
weeks of exercise.
Increased
vascularization in
rabbits with 3-weeks
exercise. VEGF mRNA
increased at 6 weeks
Petersen
et al.
2003 VEGF, VEGFR-1, and
VEGFR-2
In vivo Tenotomy of Achilles tendon in in
vivo sheep model. VEGF levels
evaluation during healing
VEGF resulted
increased in
tenotomised tendons
and not in healthy
ones. Splice variants
VEGF120 and
VEGF164 were
increased respectively
at 3 and 24 weeks
(Continued)
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TABLE 1 | Continued
Study Year Investigated
molecules
Type of
study
Type of sperimentation Role in pathogenesis Role in healing
Scott et al. 2008 VEGF In vivo Human patellar tendons with and
without tendinosis were
harvested. VEGF levels were
assessed
VEGF was
overexpressed in
intimal cells of the
vessels in affected
tendon
Nakama et al. 2006 VEGF, VEGFR-1, CTGF In vivo Cyclical loading applied to flexor
digitorum profundus in rabbits.
Expression of VEGF and
receptor, CTGF were evaluated
in loaded tendons and
contralateral ones
VEGF, VEGFR-1, and
CTGF were higher in
loaded tendon, than in
controls
Sozomor
et al.
2006 iNOS, eNOS In vivo Overuse protocol applied to
supraspinatus tendon in animal
model vs. controls, isoforms of
the NOS measurement
eNOS and iNOS were
four-fold increased
when compared to
controls
Xia et al. 2006 iNOS, NO In vivo Achilles tendon repair in murine
model iNOS−/− vs. iNOS−/−
with aminoguanidine (iNOS
inhibitor) vs. wildtype.
Microscopic healing process
evaluation and NO levels
measurement
Healing process was
comparable between
iNOS−/− and WT at 7
days from surgery. AG
delayed healing in
iNOS−/−, but NO
levels were higher in
WT group
Xia et al. 2006 NO, iNOS In vitro Tendon cells from rotator cuff
were cultured and stimulated
with NO and iNOS gene carrier.
Enzimatic inhibition was
performed
Low NO doses
promoted fibroblasts
proliferation, high NO
doses inhibited
proliferation
Lin et al. 2001 nNOS, iNOS, eNOS In vivo Achilles tendon surgery in rats
and mRNA level of NOS isoforms
measurement
All NOS isoforms were
increased during
healing
several roles in proliferation of fibroblasts, angiogenesis, and
pain transmission (Andersson et al., 2011a). Other molecules
that have been investigated include Acetylcholine (Ach) and
its receptors, Neuropeptide Y (NPY) and its receptors, and
Glutamate (Glu) and its receptors. A recent study by Fong et al.
(2013) evaluated the effect of Ach onAchilles tendon cell cultures,
showing an increased number of viable cells and proliferation,
and a phosphorylation of the epidermal growth factor receptor
(EGFR) and the extracellular signal-regulated kinases ERK1/2
that are responsible of the Ach effects. NPY and receptors Y1
and Y2 were investigated by Bjur et al. (2009), that demonstrated
by immunohistochemistry an increased expression of Y1 and
high levels of NPY in human Achilles tendinopathy cultures.
The same Authors (Bjur et al., 2008) showed that tenocytes
from tendinopathic Achilles displayed Tyrosine Hydroxylase
(TH) positive immunoreactions and reactions for TH mRNA,
in addition to α1-adrenoreceptors, showing therefore evidence
of local catecholamine production, not only at the protein
level but also at the mRNA level. The authors advanced
the hypothesis that tenocytes produce catecholamines with a
possible autocrine/paracrine effects and that they can respond
to sympathetic transmitters. Adrenergic stimuli can have an
influence on degenerative/apoptotic events but can also induce
cell proliferation (Zhang and Faber, 2001). These findings
are supported by the study of Danielson et al. (2007) that
showed in addition to immunoreactions for TH and α1-
adrenoreceptors, a positivity for α 2A-, and β1-adrenoreceptors
and for neuropeptide Y. High levels of these receptors were also
detected in the blood vessels’ walls. The same Authors (Danielson
et al., 2008) in a further study on biopsies from paratendinous
area dorsal to the proximal patellar tendon of tendinopathic
patients who underwent arthroscopy, confirmed the presence
of the immunoreaction patterns and specifically demonstrated a
marked immunoreaction for sympathetic markers in the small
and large blood vessels surrounding the abnormal tendon tissue.
Schubert et al. (2005) found in human Achilles tendinopathy
samples nerve fibers positive to Nociceptive substance P (SP), and
these were significantly increased together with an inflammatory
infiltration of B and T lymphocytes. Backman et al. in two
studies (Backman and Danielson, 2013; Backman et al., 2014)
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TABLE 2 | Nervous function and neuronal stimulation studies.
Study Year Investigated
molecules
Type of study Type of sperimentation Role in pathogenesis Role in healing
Fong et al. 2012 Ach, mAch-R,
ChAT, VAchT
in vitro Achilles tendon cells cultures
treated with Ach.
Immunohistochemical evaluation of
cells immunopatterns and EGFR
activation
Ach adimistration
increase viable cells
number, proliferation and
activation of the EGFR
and ERK1/2 pathways
Bjur et al. 2009 NPY and
receptors Y1
and Y2
in vitro Achilles tendon cell culture from
human tendon with tendinosis.
Immunohistochemical evaluation
Increased expression of Y1
receptor and NPY was found
Schubert et al. 2005 SP In vivo Achilles tendon tissue with
tendinosis vs. spontaneous rupture
without tendinosis were examined
microscopically
Increased number of SP
positive fibers was found in
tendinosis tendons, and not in
spontaneous rupture
Backman et al. 2011 SP, NK-1R In vivo Overuse protocol applied in vivo to
rabbit Achilles tendons for 1, 3 or 6
weeks vs. controls
Increased SP expression at
each time. SP and NK-1R
were found in blood vessel
walls. NK-1R was also found
on tenocytes
Lui et al. 2010 SP, CGRP In vivo Collagenase-induced tendinopathy
in patellar tendons in rats. Double
stance duration before sacrifice
assessment and
immunohistochemical evaluation
Increased SP and CGRP
were found at 2 week,
but not at 4 weeks and 8
weeks. A second peak
was at 12 weeks and 16
weeks. SP and CGRP
changes were consistent
with double stance
duration
Schizas et al. 2012 SP, NMDAR1,
p-NMDAR1,
mGluR1, 5, 6,
and 7
In vivo Immunohistochemical evaluation of
human patellar tendon tissue with
exercise-related tendinopathy
Increased expression of SP,
NMDAR1, p-NMDAR1 and
mGlutR5 was found in
comparison with controls.
Co-localization of SP and
NMDAR1 was found
showed that SP reduces the Anti-Fas-induced apoptosis in
healthy human tenocytes, and that this antiapoptotic effect of
SP is mediated through NK-1 R and Akt-specific pathways.
These findings support the role of SP in inducing the marked
hypercellularity seen in tendinopathy. The same Authors found
(Backman et al., 2011) in an animal model of Achilles tendon
overuse, that already after 1 week of overloading, the SP
levels were significantly elevated compared to a control group.
Zhou et al. (2014) showed that the injection of exogenous SP
in Achilles tendons of rats yielded to significantly increased
proliferation of pluripotent tendon cells (PTCs). Moreover,
the reverse transcription polymerase chain reaction (RT-PCR)
showed that SP upregulated the expression of non-tenocyte genes
but downregulated the expression of tenocyte-related genes.
These findings indicate that SP is responsible for enhanced PTCs’
proliferation, promotes non-tenocyte differentiation and plays an
important role in the development of tendinopathy. In a study of
Lui et al. (2010) after collagenase-induced tendinopathy of the
patellar tendon, double stance duration was evaluated and then
immunohistochemical evaluation was carried out. Increased SP
and CGRP were found at 2 weeks, but not at 4 weeks and 8
weeks. Other peaks were found at 12 weeks and 16 weeks. The
increased expression of SP and CGRP positively correlated with
the duration of double stance. The presence of increased blood
vessels and sympathetic nerve components in chronic patellar
and Achilles tendinopathy was also confirmed by the studies of
Andersson et al. (2007) and from Lian et al. (2006). Anderson
and colleagues undertook a histological study of the ventral
portion of tendinopathic Achilles tendons and demonstrated the
presence of large and small arteries and nerve fascicles. The
nerve fascicles contained sensory nerve fibers, positive for SP
and CGRP staining, and sympathetic nerve fibers (Andersson
et al., 2007). Lian and colleagues showed that chronic painful
patellar tendons exhibited increased occurrence of sprouting
nonvascular sensory, substance P–positive nerve fibers compared
to a control group (Lian et al., 2006). In a study by Schizas
et al. (2012), a relevant correlation was found between SP
and glutamate receptors in human patellar tendons affected by
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exercise-related tendinopathy. The expressions of N-methyl-D-
aspartate receptor type 1 (NMDAR1) and its phosphorylated
form (P-NMDAR) were evaluated together with SP levels and
mGlu receptors family levels. They found an increased expression
of SP, NMDAR1, p-NMDAR1, and mGlutR5, when compared
to controls. Furthermore, a significant co-localization of SP and
NMDAR1 was found exclusively in tendinopathic tendons and
not in healthy controls, suggesting a possible role of SP in
stimulating NMDAR1. These findings are supported by previous
studies such as those from Alfredson et al. (2001a,b), which
found both free glutamate and glutamate NMDAR1 receptors
in human Achilles’ tendons from patients with chronic Achilles
tendinopathy, and free glutamate and glutamate NMDAR1
receptors, but not PGE2, in patellar tendons with tendinopathy
in respect to normal tendons.
Consistently with SP’s potent effect on stimulating
proliferation of fibroblasts and endothelial cells, Burssens
et al. (2005) demonstrated as paratendinous injections of SP
after operative repair of the Achilles tendon in rats, significantly
enhanced tendon healing compared to controls. Similar
results were achieved by other authors. Steyaert et al. (2010)
reported that exogenous injections of SP yielded to enhanced
angiogenesis and fibroblast proliferation, and boosted the
endogenous substance P effects for fibroblast proliferation via
an autocrine/paracrine stimulation, though SP didn’t stimulate
sensory nerve ingrowth. Bring et al. (2012), after depleting
SP levels through Capsaicin in rats who underwent surgical
transection of the Achilles tendon, showed that rats with higher
residual SP levels developed improved tensile strength and stress
at failure in the healing of Achilles’ tendons. Carlsson et al. (2011)
showed that substance P injections enhance tissue proliferation
and regulate sensory nerve ingrowth on sutured rat’s Achilles
tendon, previously torn. The contrasting effects of Substance
P could find a possible explanation thanks to the finding from
a recent in vitro study by Zhou et al. (2014). These authors
demonstrated that adding high-doses of SP (5.0 nmol) to patellar
tendon tissue yielded to tendinopathic changes. Low doses of SP
(0.5 nmol) boosted up the tenogenesis process compared with
saline injection (control group) and the high-dose SP group.
These findings suggest that SP has a possible dose-dependent
effect: low doses could be advantageous for tendon healing,
while high SP doses can be responsible for tendinopathic
evolution.
Effects of Exogenous VEGF, NO, and SP on
Tendinopathy (Table 3)
Almost all the previously described factors have been investigated
in experimental or clinical setting to assess the biological
response to this therapy on tendinopathy.
The administration of the splice VEGF-111 in artificially
injured Achilles tendon was investigated by Kaux et al. (2014),
who showed a significantly higher strength-to-rupture of the
tendons at 15 and 30 days. Similar results were obtained by Zhang
et al. (2003), which found higher tendon strength in rats treated
with VEGF injection after Achilles tendon rupture and repair,
compared to the controls.
The use of NO has been investigated in several experimental
and clinical settings on different types of tendinopathies, and it
has been administrated clinically through a transdermal route.
Paoloni and colleagues demonstrated the beneficial effects of
glyceril trinitrate (GTN) patches on elbow extensors tendon
(McCallum et al., 2011) and on Achilles’ tendon (Paoloni et al.,
2004), with improvement of pain and function at follow-up,
especially in reducing tenderness and increasing muscle’s peak
force and total work. Comparable results were obtained by
Steunebrink et al. (2013), evaluating GTN application plus
eccentric exercise for patellar tendinopathy. Double-blinded
randomized trials (RCTs) have been conducted to assess whether
NO is useful in tendinopathy. Specifically, Paoloni et al. (2003)
investigated 86 patients with chronic extensor tendinopathy at
the elbow, undergoing to rehabilitation plus either topical NO
application in the form of GTN patch or placebo. Those patients
from the treatment group showed significantly reduced pain
at 2 weeks, as well as reduced pain during activity, reduced
tenderness at the lateral epicondyle at 6 and 12 weeks and
increased wrist extensor mean peak force at 24 weeks. In a
further study (McCallum et al., 2011) a subset of patients from
the original trial was follow-upped at 5 years, and patients from
the treatment group did not score better than those from the
placebo group. In a double-blinded RCT on patients affected
by Achilles tendinopathy, two groups were compared, either
undergoing to rehabilitation plus either GTN patch or placebo.
The treatment group demonstrated significantly reduced Achilles
activity pain at 12 weeks, reduced night pain at 12 weeks,
reduced tenderness at 12 weeks, decreased pain scores with
the hop test at 24 weeks, and an increase in ankle plantar
flexor mean total work at 24 weeks (Paoloni and Murrell,
2007). The same patients were further assessed at 3 years, and
the results showed as 88% of patients with GTN treatment
were asymptomatic at 3 years compared with 67% of patients
treated with tendon rehabilitation alone (Paoloni and Murrell,
2007).
The SP administration in tendinopathy has been extensively
studied by Burssens et al. (2005) who studied the effects of
NO in surgically repaired Achilles tendon of rats. In the
group receiving exogenous SP, increased fibroblasts proliferation,
angiogenesis and collagen fibers organization were found at
7 days post-operatively showing a faster healing of Achilles
tendons, even though there were no differences at 14 days with
the control group. An interesting study from Mousavizadeh
et al. (2015) showed that exposing human tendon cells to
dexamethasone resulted in a time-dependent reduction ofmRNA
for SP. However, it should be taken into account as there is
huge evidence that steroids negatively affect viability, migration,
proliferation, and collagen synthesis of both human and animal
tenocytes (Tsai et al., 2003; Wong et al., 2003, 2009). Zhang
et al. (2013) in fact recently demonstrated that dexamethasone
exposure induced non-tenocyte differentiation of human tendon
stem cells, determining a nearly complete suppression of collagen
type I expression, and an up-regulation of non-tenocyte related
genes (PPARg and Sox-9). Whether, this mechanism may be
mediated by an under-regulation of SP levels, has not yet been
demonstrated.
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TABLE 3 | Therapeutic studies.
Study Year Investigated
molecules
Type of study Type of sperimentation Role in healing
Lu et al. 2008 VEGF In vivo Partial patellectomy on in vivo rabbit
model. Healing stimulation through LIPUS
vs. controls. VEGF expression
measurement
VEGF expression resulted more increased
in LIPUS group than controls
Liang et al. 2012 HIF-1α, VEGF,
Bnip3, Bcl-2,
Bcl-xL
in vitro Hypoxia protocol on tenocytes cultures.
Measurement of HIF-1α, VEGF mRNA and
pro- and anti-apoptotic peptides
Insulin or PRP showed protective effects
on cell death
Kaux et al. 2014 VEGF111 In vivo VEGF111 vs. saline injection in Achilles
tendon after artificial lesion in murin model
Force for tendon rupture at 15 and 30
days was higher in VEGF111 group
Zhang et al. 2003 VEGF, TGF-β,
PDGF, bFGF,
IGF-1
In vivo Transection and suture repair of Achilles
tendon in murin model. VEGF injection at
repair site vs. saline injection. TGF-β levels
measurement
Tensile strength was higher in tendons
treated with VEGF than controls in low
terms. TGF-β was increased in VEGF
group. PDGF, bFGF, IGF-1 were
comparable
Paoloni et al. 2005 GTN In vivo Local application of GTN patch for elbow
extensors tendinopathy vs. controls.
Measurement of pain, tenderness, peak
force and total work
Exogenous NO administration improve
healing of the tendons
Paoloni et al. 2004 GTN In vivo Rehabilitation plus local application of GTN
patch for Achilles tendinopathy vs.
controls. Measurement of pain,
tenderness, peak force, and total work
Exogenous NO administration improve
healing of the tendons
Steunebrink et al. 2013 GTN In vivo Eccentric exercise plus GTN patch
application on patellar tendon vs. controls
(exercise only)
Exogenous NO administration improve
healing of the tendons
Murrell et al. 2008 NO-
paracetamol
in vitro in vitro administration of NO-paracetamol
association to tendon cell culture
Improved collagen production and
reorganization
Burssens et al. 2005 SP In vivo SP (different doses) administration to rats
after Achilles tendon repair vs. tiorphan
and captopril vs. controls. Microscopic
evaluation of fibroblasts proliferation,
angiogenesis and collagen organization
In tendons treated with SP, fibroblasts
proliferation was increased at 7 days, but
no at further f.u. Similar evolution for
angiogenesis and collagen orientation
DISCUSSION
The increasing knowledge concerning tendon dysfunction,
clinically expressed as tendinopathy, leads to the individuation
of a huge array of factors implied in the pathogenesis and
repair mechanisms of this disease. Among single molecules
and pathways involved in pathogenesis and healing process of
tendinopathy, vascular, and neuronal factors play a major role
(Papalia et al., 2013, 2015; Notarnicola et al., 2014). The first
ones are mainly involved in angiogenesis and vascular activation,
while the second ones concern signaling for cell proliferation,
collagen organization and pain transmission (Alfredson et al.,
2003). All these features are considered the core of the
pathogenesis, although their proper timing through each step of
the tendinopathy process still remains unclear. Some attempts
have been performed to find out the exact time and way of
activation of each specific pathway, quintessential to find a
targeted therapy for the tendinopathy process. From a clinical
point of view, tendinopathy represents an invalidating disease,
with a severe impact not only on sport practice, but also on daily
activities. The main challenge when facing with tendinopathy is
to provide patients with a therapy that is effective and fast-acting
and provides for durable outcome.
Some studies have investigated the role that VEGF has in both
the pathogenesis and to the healing response of tendinopathy,
also using VEGF and its splice variants as an efficient treatment
(Zhang et al., 2003; Kaux et al., 2014), that resulted in fibroblast
proliferation and angiogenesis stimulation (Kaux et al., 2014).
It has been found that VEGF and its receptor are the earlier
molecules expressed in tendinopathy (Nakama et al., 2006), and
even though the vascular hyperplasia induced by VEGF may
be considered a key factor in the pathogenesis of tendinopathy
(Scott et al., 2008), it is also the main mechanism of healing to
restore tissue integrity.
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SP administration in surgically repaired rat tendons (Burssens
et al., 2005), have also some advantages, especially in terms of
quickness of action. In addition, SP should be considered the
vault key that put together the vascular and neural function,
since it is known that SP promotes vascular activation and
vasodilatation, and also tissue hyperplasia (Zhou et al., 2014).
The local vascular activation is actually considered a still
unclear chapter of the wide topic of tendinopathy. Studies
have demonstrated an increased expression of NOS isoforms
produced by endothelium in diseased tendons (Szomor et al.,
2001). Conversely knock-out mice for iNOS did not show a
severely impaired tendon healing response (Xia et al., 2006a).
Moreover, it has been shown as NO has variable effects on tendon
tissue depending on its concentration (Xia et al., 2006b). At
present, transdermal administration of NO related drugs (namely
GTN patches) have shown a positive short-term effect in tendon
healing even in the clinical setting (Paoloni et al., 2003, 2004; Tsai
et al., 2003; Mousavizadeh et al., 2015).
However, since VEGF and its pathways are the broadly known
factors among a so complex pathogenesis, it should probably
be the main factor to pay efforts on. An interesting research
line is the regulation of VEGF action during the pathogenesis
of tendinopathy (Lu et al., 2008; Andersson et al., 2011b; Kaux
et al., 2014), which is assessing whether hypervascularization is
truly beneficial for tendon healing, and if so, in what phases of
the process. The possible answer to such contrasting data about
each of the investigated molecule (VEGF, NO, SP,) could be the
timing. Understanding the exact time of intervention of those
molecules during the tendinophaty pathogenesis and the healing
process could lead to a targeted and timed therapy to enhance
healing.
CONCLUSIONS
Vascularization and neuronal transmission play a key role in
determining the pathogenesis of the tendinopathy. The mainly
known factors implied in the process are VEGF, Substance P,
and Nitric Oxide, although their exact role in the mechanism
of tendinopathy is not well determined. More research should
be carried out, especially studies involving human subjects,
in order to assess the timing of action of those factors,
to find out how therapies targeted to the phase of the
disease process may fasten the healing process and the clinical
recovery.
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